12:00 AM
 | 
Mar 11, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Saladax, Shanghai Fosun Pharmaceutical sales and marketing update

Saladax granted a division of Shanghai Fosun exclusive commercialization rights in China to Saladax's portfolio of MyCare oncology dose...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >